Related Experiment Video
Updated: May 6, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
Aerosol therapy in children: challenges and solutions
1Georgia State University, Division of Respiratory Therapy, Atlanta, GA 30302-4019, USA.
Insights
Aerosol drug delivery for pediatric pulmonary diseases faces challenges due to adult-designed devices. This review examines devices, interfaces, and dosing to optimize aerosol therapy for children.
Area of Science:
- Pediatric Pulmonology
- Respiratory Drug Delivery
- Medical Device Engineering
Background:
- Aerosolized medication use in children is increasing.
- Existing aerosol devices are often designed for adults, posing challenges for pediatric use.
- Effective aerosol drug delivery to pediatric patients requires careful device selection and adaptation.
Purpose of the Study:
- To comprehensively review aerosol devices and interfaces for pediatric pulmonary diseases.
- To discuss dosing strategies and drug-device combinations for children.
- To identify and propose solutions for optimizing aerosol therapy in pediatric patients.
Main Methods:
- Literature review of aerosol devices and interfaces for pediatric drug delivery.
- Analysis of challenges and advantages associated with different aerosol delivery systems.
- Discussion of dosing considerations and drug-device combinations.
Main Results:
- Pediatric aerosol therapy is complex, with unique challenges compared to adults.
- Device selection and interface use significantly impact drug delivery efficiency in children.
- Various aerosol devices and interfaces have distinct benefits and drawbacks for pediatric use.
Conclusions:
- Optimizing aerosol therapy in children requires addressing specific challenges in device design and application.
- Careful consideration of dosing, drug-device combinations, and interfaces is crucial for effective pediatric aerosol treatment.
- Further research and development of pediatric-specific aerosol devices are needed.
Abstract:
Using aerosolized medications for the treatment of children has gained importance over the years. However, aerosol drug delivery to infants and pediatrics is not an easy task as it has been influenced by many challenges. Most aerosol devices have been designed for use in adults not for children. Therefore, they require some critical assessment in device selection and often a level of adaptation for use with smaller children. It is well documented that each aerosol device and interface that have been used for the treatment of children has its own advantages and challenges in drug delivery. This paper provides a comprehensive review of dosing, drug-device combination, aerosol devices and interfaces used for drug delivery to children with pulmonary diseases. Solutions to the challenges with the aim of optimizing aerosol therapy in this patient population are also discussed.
Related Concept Videos
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Inhaled Medications
Pharmacokinetics in Pediatric Patients: Drug Excretion
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Asthma-IV: Nursing Management
First, in...

